Similarly, we observed that CDK4 immunopositivity, in malignant cases (ALT/WDLS and liposarcomas), must be over 25% of the nuclei (p < 0.001) (Table 3). The gene discussed is CDK4; the disease is well-differentiated liposarcoma.